According to Gartner, 58% of finance functions employed AI in 2024—a 21-percentage-point jump from the prior year. PwC ...

"Biotech companies are solving some of the world's toughest challenges, and our mission is to give them the tools to move faster and more efficiently," said Eric Meizlish, CEO of Prendio-BioProcure.

Biotech startup Labro Inc. has raised $1.5 million in seed funding to accelerate pilot deployments of its flagship automated ...

Frost & Sullivan recognizes L7|ESP® for its unified platform architecture, workflow orchestration, and AI-ready design. AUSTIN, Texas, Oct. 29, 2025 /PRNewswire/ -- L7 Informatics, a leader in digital ...

The biotech sector is entering 2026 with a positive outlook, characterized by reasonable valuations, robust oncology momentum ...

Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.

The MarketWatch News Department was not involved in the creation of this content. AI in Biotechnology Market worth $22,716.5 million by 2035 with 18.5% CAGR | MarketsandMarkets(TM). DELRAY BEACH, Fla.

Weave is positioning itself at the forefront of pharmaceutical innovation with an AI-native platform designed to streamline regulatory workflows and accelerate drug development. Lindsay Mateo, chief ...

- Agreement Seeks to Leverage Linea IVT Platform to Enable Kudo Bio to Offer a Differentiated mRNA Manufacturing Capability with Mitigated dsRNA and Reduced Turnaround Times - STONY BROOK, NY and ...

Contracts can be difficult to maintain and track. In highly regulated industries such as the biotech pharma space, not only can a contract be complicated but so can the multitude of company ...

As ChatGPT has so aptly demonstrated, AI is now truly entering the mainstream consciousness. That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup ...